An interview with David Sackett, 2014–2015

A nonevidence‐based lyric essay on evidence‐based medicine, part II: Continuing status quo maintenance education

“…form and execute the policy that, for a research program to receive space, money, and faculty, it had to attack a problem in human biology and health care across its entire spectrum, from basic biology through treatment discovery through intervention trials and on to the assessment of the organization and effectiveness of its relevant health care. 17 Could McMaster spare some money for a department on the fabled shores of Lake Ontario that could problematize the attack of "problem[s] in human biology and health care across its entire spectrum, from basic biology through" and so on? The faith is in need of reformation.…”

A nonevidence‐based lyric essay on evidence‐based medicine, part I: What we talk about when we talk about paradigms

“…Or: Dr. David Sackett, the "Father of Evidence-Based Medicine," 5,6 has been founding chair of McMaster's novel Department of Clinical Epidemiology and Biostatistics for 8 years. 7…”

“…The residents not only showed up and learned, but became threatening to some of the faculty, and we eagerly responded to the latters' (sic) requests for their own (separate) sessions. 7 In this year, I was living in a trailer home alongside the Saint John River in Sheffield, New Brunswick. The only threats I expect I received were those inherent to living with a violent, mentally ill alcoholic.…”

“…David Sackett moves to Oxford and becomes founding Director of the National Health Service Research & Development Centre for Evidence-Based Medicine. 7 He faces some resistance here, and is particularly incensed by an editorial in the Lancet from 1995. 11 Sackett reacts to this editorial strongly, and the memory still stings in the few valedictory print and video interviews he conducts before his death.…”

Editorial

“…As a tribute to Dave's contributions both to the Society and to the journal, this issue also contains a lengthy interview that describes his views on the importance of the randomized trial. 1 The issue also includes the final ClinicalTrialist Round co-authored by Dave. …”